By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dicerna Pharmaceuticals 

480 Arsenal Street
Building 1, Suite 120
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-621-8097 Fax: n/a


Start Up

Company News
Dicerna (DRNA) Announces Appointment Of JohnJackGreen As Chief Financial Officer 4/19/2016 10:56:20 AM
Dicerna (DRNA) Announces Fourth Quarter And Full Year 2015 Financial And Operational Results 3/11/2016 10:00:32 AM
Dicerna (DRNA) To Announce Fourth Quarter And Full Year 2015 Financial Results And Host Conference Call On March 10, 2016 3/7/2016 10:25:53 AM
Dicerna (DRNA) To Present At Two March Conferences 3/3/2016 11:16:34 AM
Dicerna (DRNA) Reports Progress With GalNAc-DsiRNA-EX-Conjugates 2/25/2016 10:34:32 AM
Dicerna (DRNA) To Present At The 2016 Leerink Partners Global Healthcare Conference 2/4/2016 10:16:42 AM
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/4/2016 12:09:36 PM
Dicerna (DRNA) Begins Dosing In First Clinical Trial Of Therapy For Primary Hyperoxaluria Type 1 (PH1) In Healthy Volunteers 12/22/2015 12:05:43 PM
Dicerna (DRNA) Updates Progress On The Development Of DCR-MYC For The Treatment Of Solid Tumors 12/22/2015 12:04:10 PM
Dicerna (DRNA) Announces Addition To NASDAQ Biotechnology Index 12/17/2015 11:34:29 AM